![Michele Korfin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 488 930 $ in data 31/05/2026
Ms. Michele I.
Korfin is an Independent Director at Organogenesis Holdings, Inc. and a Chief Executive Officer at Australis Pharma.
She is on the Board of Directors at Organogenesis Holdings, Inc. Ms. Korfin was previously employed as a Chief Operating & Commercial Officer by Gamida Cell Ltd., a Chief Operating Officer by Tyme Technologies, Inc., a Vice President-Market Access by Kite Pharma, Inc., a Head-Oncology Sales Force by Celgene Corp., and a Secretary & Trustee by BioNJ, Inc. She received her undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/04/2026 | 190.245 ( 0,15% ) | 488 930 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Direttore/Membro del Consiglio | 03/05/2022 |
| Società | Posizione | Fine |
|---|---|---|
| GAMIDA CELL LTD. | Direttore operativo | 01/04/2024 |
| TYME TECHNOLOGIES, INC. | Direttore operativo | 01/01/2020 |
| KITE PHARMA INC | Corporate Officer/Principal | 01/07/2018 |
| CELGENE | Corporate Officer/Principal | 01/03/2016 |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
 Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
